Antibiotic therapy for Helicobacter pylori.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  The Medical clinics of North America

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.MCNA.2006.07.002PMID 17116440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Helicobacter pylori infection

  2013cited by this paper
• Eradication of Helicobacter pylori for non-ulcer dyspepsia.

  2011cited by this paper
• Helicobacter pylori infection.

  2009cited by this paper
• Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

  2006cited by this paper
• Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.

  2006cited by this paper
• Eradication of Helicobacter pylori for non-ulcer dyspepsia.

  2006cited by this paper
• Cost-effectiveness of Helicobacter pylori “test and treat” for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: A Markov model analysis

  2006cited by this paper
• Pathogenesis of Helicobacter pylori Infection

  2006cited by this paper
• Third-Line Rescue Therapy with Levofloxacin After Two H. pylori Treatment Failures

  2006cited by this paper
• Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.

  2005cited by this paper
• Helicobacter pylori“Rescue” Therapy After Failure of Two Eradication Treatments

  2005cited by this paper
• Helicobacter pylori VacA, a paradigm for toxin multifunctionality

  2005cited by this paper
• Helicobacter pylori first‐line treatment and rescue options in patients allergic to penicillin

  2005cited by this paper
• Pathogenesis of Helicobacter pylori Infection

  2005cited by this paper
• A 10‐day levofloxacin‐based triple therapy in patients who have failed two eradication courses

  2005cited by this paper
• Treatment of Helicobacter pylori

  2005cited by this paper
• Eradication of Helicobacter pylori significantly reduced gastric damage in nonsteroidal anti-inflammatory drug-treated Mongolian gerbils.

  2005cited by this paper
• Proton‐pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non‐steroidal anti‐inflammatory drugs

  2004cited by this paper
• Gastric B‐cell mucosa‐associated lymphoid tissue (MALT) lymphoma in an animal model of ‘Helicobacter heilmannii’ infection

  2004cited by this paper
• Seven‐day therapy for Helicobacter pylori in the United States

  2004cited by this paper
• Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

  2004cited by this paper
• The effect of Helicobacter pylori and its eradication on gastro‐oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis

  2004cited by this paper
• Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: A Prospective, Randomized, Multicenter, North A

  2003cited by this paper
• Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series

  2003cited by this paper
• A Prospective, Randomized Study of Quadruple Therapy and High‐Dose Dual Therapy for Treatment of Helicobacter Pylori Resistant to Both Metronidazole and Clarithromycin

  2003cited by this paper
• A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.

  2003cited by this paper
• Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review

  2003cited by this paper
• Triple vs. quadruple therapy for treating Helicobacter pylori infection: an updated meta‐analysis

  2003cited by this paper
• A) Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease.

  2003cited by this paper
• Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second‐line treatment for Helicobacter pylori infection

  2003cited by this paper
• Eradication of Helicobacter pylori by 7‐Day Triple‐Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double‐Blind, Randomized Studies

  2003cited by this paper
• Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults

  2003cited by this paper
• Helicobacter pylori and reflux disease

  2003cited by this paper
• Natural history and epidemiology of Helicobacter pylori infection

  2002cited by this paper
• Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report

  2002cited by this paper
• Furazolidone‐based triple ‘rescue therapy’ vs. quadruple ‘rescue therapy’ for the eradication of Helicobacter pylori resistant to metronidazole

  2002cited by this paper
• Recovery Rate and Prognosis in Older Persons Who Develop Acute Lung Injury and the Acute Respiratory Distress Syndrome

  2002cited by this paper
• Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection

  2002cited by this paper
• Impact of Furazolidone‐Based Quadruple Therapy for Eradication of Helicobacter pylori after Previous Treatment Failures

  2002cited by this paper
• Rifabutin‐based Helicobacter pylori eradication ‘rescue therapy’

  2001cited by this paper
• Helicobacter pylori infection in children.

  2001cited by this paper
• Helicobacter Pylori: Physiology and Genetics

  2001cited by this paper
• Randomized study of two “rescue” therapies for helicobacter pylori-infected patients after failure of standard triple therapies

  2001cited by this paper
• Ranitidine bismuth citrate‐based triple therapies after failure of the standard ‘Maastricht triple therapy’: a promising alternative to the quadruple therapy?

  2001cited by this paper
• The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease

  2001cited by this paper
• Key points from the revised Maastricht Consensus Report: the impact on general practice.

  2001cited by this paper
• Antibiotic susceptibility and resistance

  2001cited by this paper
• Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?

  2001cited by this paper
• Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study

  2000cited by this paper
• Histological identification of Helicobacter pylori: comparison of staining methods

  2000cited by this paper
• Immunology of Helicobacter pylori and prospects for vaccine.

  2000cited by this paper
• Accurate diagnosis of Helicobacter pylori. 13C-urea breath test.

  2000cited by this paper
• A meta‐analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

  2000cited by this paper
• Accurate diagnosis of Helicobacter pylori. Urease tests.

  2000cited by this paper
• Rifabutin-based Triple Therapy After Failure of Helicobacter pylori Eradication Treatment: Preliminary Experience

  2000cited by this paper
• Latin-American Consensus Conference on Helicobacter pylori infection

  2000cited by this paper
• Quantitative culture of Helicobacter pylori from gastric juice: the potential for transmission.

  2000cited by this paper
• Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States.

  2000cited by this paper
• Latin-American Consensus Conference on Helicobacter pylori infection 1 1 A list of delegates to the

  2000cited by this paper
• High Prevalence of Helicobacter pylori in the Alaska Native Population and Association with Low Serum Ferritin Levels in Young Adults

  2000cited by this paper
• Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

  2000cited by this paper
• Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group.

  1999cited by this paper
• Effectiveness of Helicobacter pylori therapies in a clinical practice setting.

  1999cited by this paper
• Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysis

  1999cited by this paper
• A Practical Approach to Patients with Refractory Helicobacter pylori Infection, or Who Are Re-Infected After Standard Therapy

  1999cited by this paper
• Fecal and oral shedding of Helicobacter pylori from healthy infected adults.

  1999cited by this paper
• The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.

  1999cited by this paper
• Reliability of biopsy-based diagnostic tests for Helicobacter pylori after treatment aimed at its eradication.

  1999cited by this paper
• The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer

  1999cited by this paper
• Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.

  1999cited by this paper
• The DU‐MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy

  1999cited by this paper
• A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori.

  1998cited by this paper
• Guidelines for the management of Helicobacter pylori infection

  1998cited by this paper
• Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials

  1998cited by this paper
• Treatment of Helicobacter Pylori Infection

  1998cited by this paper
• Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease : Results of three multicenter, double-blind, united states trials

  1998cited by this paper
• Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection

  1997cited by this paper
• Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori.

  1997cited by this paper
• Diagnostic tests for Helicobacter pylori infection.

  1997cited by this paper
• Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis.

  1996cited by this paper
• Microdose 14C-urea breath test offers diagnosis of Helicobacter pylori in 10 minutes.

  1996cited by this paper
• Detection of Helicobacter pylori in gastric biopsy and resection specimens.

  1996cited by this paper
• Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study

  1996cited by this paper
• [13C]urea breath test to confirm eradication of Helicobacter pylori.

  1995cited by this paper
• Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection.

  1995cited by this paper
• NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.

  1994cited by this paper
• Helicobacter pylori in peptic ulcer disease.

  1994cited by this paper
• Patient factors affecting Helicobacter pylori eradication with triple therapy.

  1993cited by this paper
• Isolation of Helicobacter pylori from human faeces.

  1992cited by this paper
• Helicobacter pylori infection and the risk of gastric carcinoma.

  1991cited by this paper
• Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group.

  1991cited by this paper
• Water source as risk factor for Helicobacter pylori infection in Peruvian children

  1991cited by this paper
• Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons.

  1989cited by this paper
• Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

  1984cited by this paper

• 100% WHEY (LACTOWHEY): Pure Whey Protein Concentrate Sourced from Cows not Treated with Hormones & Added with Natural Plant Enzymes for Protein Digestion

  2021cites this paper
• High frequency of metronidazole and clarithromycin-resistant Helicobacter pylori in formalin-fixed, paraffin-embedded gastric biopsies

  2018cites this paper
• Advances and Opportunities in Nanoparticle‐ and Nanomaterial‐Based Vaccines against Bacterial Infections

  2018cites this paper
• A Modern View on the Issue of Enterosorption : Choosing the Optimal Drug

  2017cites this paper
• Future Challenges of Whey Proteins

  2015cites this paper
• Prevalence Rate of Adverse Drug Reactions Caused by Eradicating Helicobacter Pylori in the Patients Treated by a Sequential Regimen. J. Life Sci. Biomed. 5(1): 11-14.;

  2015cites this paper
• A Modern View on the Issue of Enterosorption : Choosing the Optimal Drug

  2014cites this paper
• Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication

  2013cites this paper
• An exploratory study of Helicobacter suis control strategies

  2013cites this paper
• Health Benefits of Whey Protein: A Review

  2012cites this paper
• The comparison between two treatment methods for H. pylori eradication with two-week sequential regimens

  2012cites this paper
• ارزیابی شیوع جهشهای A2143G، A2142G و A2142C در ایجاد مقاومت به کلاریترومایسین در سویههای هلیکوباکتر پیلوری جدا شده از استان چهارمحال و بختیاری

  2010cites this paper
• Urease de Helicobacter pylori : ativação de plaquetas e neutrófilos

  2010cites this paper
• Helicobacter pylori infection: Update on diagnosis and management

  2010cites this paper
• Development of vaccines against Helicobacter pylori

  2009cites this paper
• The effect of proton pump inhibitors (PPIs) on the orientation of Helicobacter pylori in the gastric mucus of the Mongolian gerbil in vivo .

  2008cites this paper
• Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.

  2008cites this paper
• Competitive Inhibitors of Helicobacter pylori Type II Dehydroquinase: Synthesis, Biological Evaluation, and NMR Studies

  2008cites this paper
• Gastritis y úlcera

  2007cites this paper
• Pharmacokinetic Characteristics of Lafutidinein Healthy Subjects

  2007cites this paper
• An Alternative Salvage Regimen for Helicobacter pylori-Resistant Patients with Heart Failure

  2007cites this paper
• Bacterial, Viral and Fungal Infection Factors in Aetiophathogenesis of Alzheimer’s Disease

  year unknowncites this paper